The living, innovative, fully engineered, long-lasting and advanced bioreplacement research program: when Italian Regional Institutions support research.

Published on Jun 1, 2021in Regenerative Medicine2.598
· DOI :10.2217/RME-2021-0040
Assunta Fabozzo7
Estimated H-index: 7
(UNIPD: University of Padua),
Giorgia Cassandro + 1 AuthorsGino Gerosa57
Estimated H-index: 57
(UNIPD: University of Padua)
Source
Abstract
Tweetable abstract Born with the aim of creating tissues and organs for transplant, the LIFELAB research program represents a unique reality in Italy. The program has gained promising results in the first phase, due to the synergy of 21 groups of researchers.
📖 Papers frequently viewed together
18 Citations
98 Citations
176 Citations
References5
Newest
#1Sandro SpongaH-Index: 11
#2Antonella Bonetti (University of Udine)H-Index: 9
Last. Ugolino Livi (University of Udine)H-Index: 32
view all 9 authors...
BACKGROUND The aim of this study was to match clinical outcomes of heart transplantation (HTx) against histopathologic and ultrastructural characteristics of marginal grafts preserved by cold storage (CS) or ex vivo normothermic perfusion. METHODS Since 2011, 100 patients had undergone HTx at our institution by using marginal donors (aged ≥55 years, expected ischemic time of >4 hours, left ventricular ejection fraction of ≤50%, interventricular septum thickness of ≥14 mm, drug abuse history, epi...
1 CitationsSource
#1Theodore Zhang (BCM: Baylor College of Medicine)H-Index: 2
#2Jordan Dunson (BCM: Baylor College of Medicine)H-Index: 1
Last. Abbas Rana (BCM: Baylor College of Medicine)H-Index: 25
view all 8 authors...
Importance Investigating outcomes after marginal allograft transplant is essential in determining appropriate and more aggressive use of these allografts. Objective To determine the time trends in the outcomes of marginal liver allografts as defined by 6 different sets of criteria. Design, Setting, and Participants In this case-control, multicenter study, 75 050 patients who received a liver transplant between March 1, 2002, and September 30, 2016, were retrospectively analyzed to last known fol...
6 CitationsSource
#1Anna Urciuolo (UNIPD: University of Padua)H-Index: 15
#2Ilaria PoliH-Index: 1
Last. Nicola ElvassoreH-Index: 46
view all 15 authors...
Fabrication of three-dimensional (3D) structures and functional tissues directly in live animals would enable minimally invasive surgical techniques for organ repair or reconstruction. Here, we show that 3D cell-laden photosensitive polymer hydrogels can be bioprinted across and within tissues of live mice, using bio-orthogonal two-photon cycloaddition and crosslinking of the polymers at wavelengths longer than 850 nm. Such intravital 3D bioprinting—which does not create by-products and takes ad...
33 CitationsSource
#1Francesca Sensi (Ca' Foscari University of Venice)H-Index: 1
#1Francesca Sensi (Ca' Foscari University of Venice)H-Index: 6
Last. Marco Agostini (UNIPD: University of Padua)H-Index: 27
view all 14 authors...
Colorectal cancer (CRC) shows highly ineffective therapeutic management. An urgent unmet need is the random assignment to adjuvant chemotherapy of high-risk stage II and stage III CRC patients without any predictive factor of efficacy. In the field of drug discovery, a critical step is the preclinical evaluation of drug cytotoxicity, efficacy, and efficiency. We proposed a patient-derived 3D preclinical model for drug evaluation that could mimic in vitro the patient's disease. Surgically resecte...
11 CitationsSource
#1Andrea Porzionato (UNIPD: University of Padua)H-Index: 40
#2Elena Stocco (UNIPD: University of Padua)H-Index: 10
Last. Raffaele De Caro (UNIPD: University of Padua)H-Index: 41
view all 6 authors...
Tissue engineering and regenerative medicine involve many different artificial and biologic materials, frequently integrated in composite scaffolds, which can be repopulated with various cell types. One of the most promising scaffolds is decellularized allogeneic extracellular matrix (ECM) then recellularized by autologous or stem cells, in order to develop fully personalized clinical approaches. Decellularization protocols have to efficiently remove immunogenic cellular materials, maintaining t...
87 CitationsSource
Cited By0
Newest